Olivier Jean Bohuon
Director/Board Member presso RECKITT BENCKISER GROUP PLC
Patrimonio netto: 65 491 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Helen Barraclough | F | 45 |
Smith & Nephew A/S (Denmark)
 Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 11 anni |
| Roland Diggelmann | M | 57 |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 6 anni |
| Stéphane Thiroloix | M | - |
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | 6 anni |
| Catheryn O'Rourke | F | 52 | 11 anni | |
| Erik Engstrom | M | 60 |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 9 anni |
| Ian Clark | M | 62 | 7 anni | |
| Christophe Weber | M | 57 | 10 anni | |
| Steven Gillis | M | 71 | 12 anni | |
| Pamela Kirby | M | 70 | 22 anni | |
| Michael Friedman | M | 80 |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 7 anni |
| Marc E. Owen | M | 65 |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 7 anni |
| Katarzyna Mazur-Hofsaess | M | 60 |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 14 anni |
| Andrew Plump | M | 58 | 9 anni | |
| Masami Iijima | M | 73 | 3 anni | |
| Shannon Eisenhardt | M | - | 1 anni | |
| Constantine Saroukos | M | 53 | 9 anni | |
| Kris Licht | M | - | 5 anni | |
| Hubert Allen | M | 58 | 18 anni | |
| Cyrille Yann Nicolas Petit | M | 54 | 12 anni | |
| Fredrik Thorell | M | - |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | 7 anni |
| Norimasa Takeda | M | - | - | |
| Takashi Okubo | M | - | - | |
| Sébastien Huron | M | 54 | 18 anni | |
| Susan O’Reilly | F | - | 5 anni | |
| Karin Hoeing | F | - | 4 anni | |
| Bradley Cannon | M | 56 | 12 anni | |
| Kimberly Reed | F | 53 | 2 anni | |
| Fabrice Beaulieu | M | - | 25 anni | |
| Koji Hatsukawa | M | 72 | 8 anni | |
| Miki Tsusaka | F | 61 | 1 anni | |
| Habib Ramdani | M | 48 | 8 anni | |
| Dame Dowling | M | 71 | 6 anni | |
| Sandrine Brunel | F | - | 26 anni | |
| Edmund Harrigan | M | 71 |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | 3 anni |
| Haruhiko Hirate | M | - | - | |
| Rick Medlock | M | 64 |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 4 anni |
| Yoshiaki Fujimori | M | 71 | 8 anni | |
| Jean-Luc Butel | M | 67 | 8 anni | |
| Michel Garaudet | M | 69 | 22 anni | |
| Elane Stock | F | 59 | 6 anni | |
| Pam Cheng | F | 53 | 4 anni | |
| Christopher Sinclair | M | 72 | 9 anni | |
| David Darroch | M | 61 | 2 anni | |
| Andrew Bonfield | M | 61 | 6 anni | |
| Emiko Higashi | F | 64 | 8 anni | |
| Roberto Quarta | M | 75 |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | 11 anni |
| Petri T. Vainio | M | 65 |
Laboratoires Majorelle SAS
 Laboratoires Majorelle SAS Medical DistributorsDistribution Services Laboratoires Majorelle SAS operates as an independent French pharmaceutical company. Its products include Vitaros, Optilov, Keat range, and Carmex. The company was founded by Guillaume El Glaoui in 2012 and is headquartered in Paris, France.
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | 20 anni |
| Robert Alpern | M | 73 | 16 anni | |
| Angela Risley | F | 66 | 7 anni | |
| Mary Harris | F | 58 | 9 anni | |
| Philippe Capron | M | 65 | 20 anni | |
| Mehmood Khan | M | 66 | 6 anni | |
| Michel Orsinger | M | 66 | 8 anni | |
| Richard Kolodziejcyk | M | - |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | 24 anni |
| Scott A. Byrd | M | 54 |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | - |
| Lauren Duprey | F | 40 | - | |
| Bertrand Havrileck | M | - | 30 anni | |
| Nathalie Pollet | F | - | 31 anni | |
| Volker Kuhn | M | - | 4 anni | |
| Pradeep Krishnamurthi | M | - | - | |
| Ranjay Radhakrishnan | M | - | 4 anni | |
| James Dinniss | M | - | 5 anni | |
| Anthony Grannell | M | - | 5 anni | |
| Paul Keogh | M | - | 5 anni | |
| Anthony Denis Ahern | M | - | 5 anni | |
| Pierre Madelpuech | M | 63 | 29 anni | |
| Charles Reynolds | M | - | 13 anni | |
| Brooks William Andrews | M | - |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | 11 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David J. Illingworth | M | 70 | 9 anni | |
| Richard Gonzalez | M | 70 | 33 anni | |
| Jeffrey Leiden | M | 68 | 6 anni | |
| Nicandro Durante | M | 67 | 10 anni | |
| Gitte Pugholm Aabo | F | 57 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 27 anni |
| Jeffrey Poulton | M | 56 | 14 anni | |
| Scott Applebaum | M | 57 | 2 anni | |
| Masato Iwasaki | M | 65 | 38 anni | |
| S. Mathew | F | 68 | 7 anni | |
| Christian Karst | M | 66 | 36 anni | |
| Kevin R. Tebbit | M | 76 | 12 anni | |
| Susan Kilsby | F | 65 | 8 anni | |
| Catherine Mazzacco | F | 59 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 2 anni |
| Anne Minto | F | 70 | 8 anni | |
| David Altarac | M | 63 | - | |
| Sun Kim | M | 52 | 2 anni | |
| Christoph Brackmann | M | - | - | |
| Ludovic Robin | M | - | 8 anni | |
| Graham Baker | M | 56 | 3 anni | |
| Phebe Novakovic | F | 66 | 11 anni | |
| William Burns | M | 76 | 8 anni | |
| Jeff Carr | M | 61 | 4 anni | |
| John Gordon Buchanan | M | 79 | 9 anni | |
| David John Kappler | M | 76 | 12 anni | |
| Edward Liddy | M | 78 | 11 anni | |
| David R. Ginsburg | M | 71 | 8 anni | |
| William R. Mordan | M | 54 | 4 anni | |
| Geneviéve B. Berger | M | 69 | 2 anni | |
| Michael Frazzette | M | 61 | 11 anni | |
| Richard de Schutter | M | 83 | 13 anni | |
| Namal Nawana | M | 53 | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Regno Unito | 39 | 39.39% |
| Irlanda | 20 | 20.20% |
| Giappone | 18 | 18.18% |
| Francia | 14 | 14.14% |
| Stati Uniti | 11 | 11.11% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Olivier Jean Bohuon
- Contatti personali
